Dare Bioscience (DARE) Prepaid Assets (2016 - 2026)
Dare Bioscience's (DARE) quarterly Prepaid Assets came in at $2.4 million in Q4 2025, down 14.44% YoY from $2.7 million in Q4 2024, and up 4325.45% on a QoQ basis from $53159.0 in Q3 2025.
Dare Bioscience (DARE) Prepaid Assets (2016 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 10 years of Prepaid Assets data on file, last reported at $2.4 million in Q4 2025.
- Quarterly Prepaid Assets fell 14.44% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (down 14.44% YoY) and the FY2025 annual result came in at $2.4 million, down 14.44% from the prior year.
- Prepaid Assets climbed to $2.4 million in Q4 2025, from $53159.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $8.1 million in Q2 2023 to a low of $53159.0 in Q3 2025.
- A 5-year average of $4.1 million and a median of $3.4 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 313.56% — and 2025, when it plunged 98.34%.
- Tracing DARE's Prepaid Assets over 5 years: stood at $2.5 million in 2021, then jumped by 169.16% to $6.7 million in 2022, then retreated by 8.22% to $6.1 million in 2023, then tumbled by 55.06% to $2.7 million in 2024, then dropped by 14.44% to $2.4 million in 2025.
- The last three Prepaid Assets figures came in at $2.4 million (Q4 2025), $53159.0 (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.78 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Sep 30, 2025 | 53,159.00 |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 3.19 Mn |
| Jun 30, 2024 | 3.51 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | 6.58 Mn |
| Jun 30, 2023 | 8.07 Mn |
| Mar 31, 2023 | 7.08 Mn |
| Dec 31, 2022 | 6.67 Mn |
| Sep 30, 2022 | 6.89 Mn |
| Jun 30, 2022 | 5.90 Mn |
| Mar 31, 2022 | 6.77 Mn |
| Dec 31, 2021 | 2.48 Mn |
| Sep 30, 2021 | 2.52 Mn |
| Jun 30, 2021 | 1.99 Mn |